Benzinga | Nov 3, 2021 09:15AM EDT

Intercept Pharmaceuticals Q3 EPS $(0.63) Beats $(1.09) Estimate, Sales $92.83M Beat $83.02M Estimate

Intercept Pharmaceuticals (NASDAQ:ICPT) reported quarterly losses of $(0.63) per share which beat the analyst consensus estimate of $(1.09) by 42.2 percent. This is a 60.87 percent increase over losses of $(1.61) per share from the same period last year. The company reported quarterly sales of $92.83 million which beat the analyst consensus estimate of $83.02 million by 11.81 percent. This is a 16.73 percent increase over sales of $79.52 million the same period last year.